Literature DB >> 28429661

Understanding sex differences in health status: A frontier in the field of vascular medicine.

Ryan J Mays1,2,3, Judith G Regensteiner2,3,4.   

Abstract

Entities:  

Keywords:  peripheral artery disease; quality of life; sex differences

Mesh：

Year:  2017        PMID： 28429661      PMCID： PMC5760173          DOI： 10.1177/1358863X17691625

Source DB:  PubMed          Journal:  Vasc Med        ISSN： 1358-863X            Impact factor:   3.239


× No keyword cloud information.
  9 in total

1.  A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association.

Authors:  Alan T Hirsch; Matthew A Allison; Antoinette S Gomes; Matthew A Corriere; Sue Duval; Abby G Ershow; William R Hiatt; Richard H Karas; Marge B Lovell; Mary M McDermott; Donna M Mendes; Nancy A Nussmeier; Diane Treat-Jacobson
Journal:  Circulation       Date:  2012-02-15       Impact factor: 29.690

2.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

3.  Sex differences in disease-specific health status measures in patients with symptomatic peripheral artery disease: Data from the PORTRAIT study.

Authors:  Mazen Roumia; Herbert D Aronow; Peter Soukas; Kensey Gosch; Kim G Smolderen; John A Spertus; J Dawn Abbott
Journal:  Vasc Med       Date:  2017-03-14       Impact factor: 3.239

4.  Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization.

Authors:  David M Safley; John A House; Steven B Laster; William C Daniel; John A Spertus; Steven P Marso
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

Review 5.  Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options.

Authors:  Jeffrey W Olin; Christopher J White; Ehrin J Armstrong; Daniella Kadian-Dodov; William R Hiatt
Journal:  J Am Coll Cardiol       Date:  2016-03-22       Impact factor: 24.094

6.  Prevalence and predictors of persistent health status impairment in patients referred to a vascular clinic with intermittent claudication.

Authors:  D M Safley; K F Kennedy; G Stansby; M Flather; D J Cohen; J A Spertus
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-03-03       Impact factor: 7.069

7.  Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Michael R Jaff; Michael W Steffes; Anthony J Comerota; Jonathan Ehrman; Diane Treat-Jacobson; M Eileen Walsh; Tracie Collins; Dalynn T Badenhop; Ulf Bronas; Alan T Hirsch
Journal:  Circulation       Date:  2011-11-16       Impact factor: 29.690

8.  Gender and peripheral arterial disease.

Authors:  Tracie C Collins; Maria Suarez-Almazor; Ruth L Bush; Nancy J Petersen
Journal:  J Am Board Fam Med       Date:  2006 Mar-Apr       Impact factor: 2.657

9.  Gender differences in health status and adverse outcomes among patients with peripheral arterial disease.

Authors:  Rachel P Dreyer; Moniek van Zitteren; John F Beltrame; Robert Fitridge; Johan Denollet; Patrick W Vriens; John A Spertus; Kim G Smolderen
Journal:  J Am Heart Assoc       Date:  2014-12-23       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.